CONSULTING SERVICES AGREEMENTConsulting Services Agreement • March 6th, 2009 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Delaware
This Consulting Services Agreement (“Agreement”) is made effective the 1st day of April 2008 (the “Effective Date”), by and between Emergent BioSolutions Inc. (“Emergent”), a Delaware corporation, with offices at 2273 Research Boulevard, Suite 400, Rockville, Maryland 20850, and The Hauer Group (“Consultant”), located at 7850 Southdown Road, Alexandria, VA 22308, Emergent and Consultant are sometimes hereinafter referred to in the singular as “Party” and collectively as the “Parties”.
AMENDED AND RESTATED MARKETING AGREEMENTMarketing Agreement • March 6th, 2009 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Michigan
This Amended and Restated Marketing Agreement (the "Agreement") is made effective as of the 5th day of November 2008 (the "Effective Date"), by and between Emergent BioDefense Operations Lansing Inc. (formerly known as BioPort Corporation), a Michigan corporation having offices at 3500 N. Martin Luther King, Jr., Blvd., Lansing Michigan 48906 ("Emergent") and Intergen N.V., a corporation of the Netherlands Antilles, its address being c/o Tarma Trust Management, Castorweg 22-24, Curacao, Netherlands Antilles ("Intergen") (Emergent and Intergen each a "Party" and collectively the "Parties").
LICENSE AGREEMENTLicense Agreement • March 6th, 2009 • Emergent BioSolutions Inc. • Pharmaceutical preparations • District of Columbia
THIS LICENSE AGREEMENT (“Agreement”), effective as of the “Signature Date” (as defined below), is made by and between: U.S. Army Medical Research Institute of Infectious Diseases (“Licensor”), a subordinate laboratory of the United States Army Medical Research and Materiel Command, having a place of business at 504 Scott Street, Fort Detrick, Maryland 21702-5012; and VaxGen Inc. (“Licensee”) a Delaware corporation, having a principal place of business at 1000 Marina Boulevard, Brisbane, California 94005-1841.
